AIRLINK 78.55 Decreased By ▼ -0.06 (-0.08%)
BOP 4.77 Increased By ▲ 0.12 (2.58%)
CNERGY 4.16 Increased By ▲ 0.13 (3.23%)
DFML 39.29 Increased By ▲ 2.81 (7.7%)
DGKC 95.65 Increased By ▲ 7.40 (8.39%)
FCCL 24.16 Increased By ▲ 1.87 (8.39%)
FFBL 32.77 Increased By ▲ 2.62 (8.69%)
FFL 9.37 Increased By ▲ 0.19 (2.07%)
GGL 10.15 Increased By ▲ 0.23 (2.32%)
HASCOL 6.54 Increased By ▲ 0.43 (7.04%)
HBL 109.50 Increased By ▲ 4.50 (4.29%)
HUBC 145.01 Increased By ▲ 7.51 (5.46%)
HUMNL 10.73 Increased By ▲ 0.08 (0.75%)
KEL 4.73 Increased By ▲ 0.09 (1.94%)
KOSM 4.26 Increased By ▲ 0.26 (6.5%)
MLCF 39.40 Increased By ▲ 2.27 (6.11%)
OGDC 129.25 Increased By ▲ 10.06 (8.44%)
PAEL 25.87 Increased By ▲ 1.89 (7.88%)
PIBTL 6.34 Increased By ▲ 0.27 (4.45%)
PPL 122.70 Increased By ▲ 8.65 (7.58%)
PRL 24.35 Increased By ▲ 1.18 (5.09%)
PTC 12.99 Increased By ▲ 0.79 (6.48%)
SEARL 61.18 Increased By ▲ 2.13 (3.61%)
SNGP 65.20 Increased By ▲ 3.22 (5.2%)
SSGC 9.89 Increased By ▲ 0.13 (1.33%)
TELE 7.86 Increased By ▲ 0.19 (2.48%)
TPLP 9.85 Increased By ▲ 0.37 (3.9%)
TRG 64.50 Increased By ▲ 0.78 (1.22%)
UNITY 26.99 Increased By ▲ 0.14 (0.52%)
WTL 1.32 Increased By ▲ 0.02 (1.54%)
BR100 7,989 Increased By 410.8 (5.42%)
BR30 25,633 Increased By 1415.1 (5.84%)
KSE100 76,208 Increased By 3410.7 (4.69%)
KSE30 24,438 Increased By 1225 (5.28%)

Pfizer Inc

Indian shares rise
Markets

Indian shares rise

BENGALURU: Indian shares ended higher on Monday, led by financial and energy stocks, while Pfizer Inc’s local arm...
Published 09 Nov, 2021 04:48am
Pfizer lifts sales forecast for COVID-19 vaccine to $26 billion
Business & Finance

Pfizer lifts sales forecast for COVID-19 vaccine to $26 billion

  • It is expected to make up for more than one-third of Pfizer's full-year sales, with the company in supply talks with several countries for 2022 and beyond.
  • "Based on what we've seen, we believe that a durable demand for our COVID-19 vaccine - similar to that of the flu vaccines - is a likely outcome," Chief Executive Albert Bourla said in his prepared remarks.
Published 04 May, 2021 07:48pm
Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU
Business & Finance

Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU

  • The companies filed a similar request in the United States earlier this month for the vaccine, which is already authorized for use in people from 16 years of age in both the United States and the European Union.
  • The submissions are based on positive data from a late-stage clinical trial that enrolled 2,260 participants aged 12 to 15, the companies said.
Published 30 Apr, 2021 04:51pm